Pharmaceuticals

Rocket Pharmaceuticals Investors Urged to Join Class Action Ahead of August 11 Deadline, Claims of Misleading Trial Data Surface

by

NEW YORK — Investors who purchased shares of Rocket Pharmaceuticals, Inc. between February 27 and May 26, 2025, are being reminded of an upcoming deadline related to a class action lawsuit. The Rosen Law Firm, a prominent global investor rights law firm, has announced that August 11, 2025, is the last day to apply as a lead plaintiff in this case. Those who bought securities of Rocket Pharmaceuticals during the specified period may be eligible for compensation without any upfront costs. Prospective participants can contact Phillip Kim, a legal representative from Rosen Law Firm, for … Read more

RCKT Investors Gear Up to Champion Lawsuit Against Rocket Pharmaceuticals for Alleged Securities Fraud

by

Rocket Pharmaceuticals, Inc., a biotechnology company based in Morrisville, North Carolina, is facing a potential securities fraud lawsuit. This issue has raised concerns among investors who believe they may have been misled regarding the company’s financial stability and performance. Several allegations suggest that Rocket Pharmaceuticals may have provided misleading information about its operations and clinical trials. Investors who purchased securities during a specified period could potentially lead a class-action lawsuit, claiming they suffered losses due to these misrepresentations. Legal experts are suggesting that those affected should review their options carefully to determine whether they qualify … Read more

Legal Showdown: Boies Schiller Flexner Faces Off Against Former Counsel in Florida Pharmaceuticals Case

by

In Miami, Florida, a contentious legal dispute has erupted involving Boies Schiller Flexner LLP and its representation within the pharmaceutical mass tort sector. The case marks a significant intersection of law and healthcare, highlighting tensions between established firms and their former legal counsels. The conflict centers around allegations related to the management of mass tort litigations, which are designed to allow multiple individuals to bring claims against a defendant simultaneously. These lawsuits often arise from large-scale issues, such as pharmaceutical injuries, whereby numerous plaintiffs seek compensation for harm caused by a particular drug or medical … Read more

Crucial Legal Battle Looms as Hikma Pharmaceuticals and Plaintiffs Spar in Court Over U.S. Patent Dispute

by

Los Angeles, California — Hikma Pharmaceuticals is gearing up for a pivotal antitrust trial set for next month in a California federal court, where it faces a class action lawsuit alleging unfair practices related to the U.S. patent system. The latest pretrial hearing, which took place Thursday, saw attorneys for both sides engage in a robust debate over the admissibility of key witness testimony and the proper jury instructions for the upcoming trial. The dispute centers on claims that Hikma Pharmaceuticals engaged in anti-competitive behaviors that negatively impacted other competitors and consumers. Plaintiffs in the … Read more